Deutsche Bank
BLPH

Deutsche Bank’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Deutsche Bank’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,864
Closed -$15K – 5020
2021
Q1 		$15K Sell
2,864
-270
-9% -$1.88K ﹤0.01% 4416
2020
Q4 		$21K Buy
3,134
+885
+39% +$7.25K ﹤0.01% 4243
2020
Q3 		$23K Buy
2,249
+665
+42% +$7.82K ﹤0.01% 4099
2020
Q2 		$20K Buy
+1,584
New +$22.2K ﹤0.01% 4049
2017
Q3 		– Sell
-13
Closed – – 5206
2017
Q2 		$0 Buy
+13
New +$269 ﹤0.01% 5219
2015
Q3 		– Sell
-171
Closed -$20K – 5433
2015
Q2 		$20K Buy
+171
New +$23.2K ﹤0.01% 4906

Other funds holding BLPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Deutsche Bank's BLPH Position: Q2 2021 in Review

Deutsche Bank sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q2 2021, closing a stake of 2,864 shares — an estimated $15K sold.

Deutsche Bank first reported a position in BLPH in Q2 2015 and held it in 6 quarters. The position peaked at $23K in Q3 2020. 27 funds tracked by Wall St. Rank hold BLPH as of Q2 2021.

  • Deutsche Bank reported no remaining Bellerophon Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 2,864 Bellerophon Therapeutics, Inc. shares in Q2 2021, an estimated $15K.
  • Deutsche Bank first reported a position in Bellerophon Therapeutics, Inc. in Q2 2015 and held it in 6 quarters.
  • Deutsche Bank's Bellerophon Therapeutics, Inc. position peaked at $23K in Q3 2020.
  • 27 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.